Health effects of long-term use of the intrauterine levonorgestrel-releasing system - A follow-up study over 12 years of continuous use

Citation
M. Ronnerdag et V. Odlind, Health effects of long-term use of the intrauterine levonorgestrel-releasing system - A follow-up study over 12 years of continuous use, ACT OBST SC, 78(8), 1999, pp. 716-721
Citations number
11
Categorie Soggetti
Reproductive Medicine
Journal title
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
ISSN journal
00016349 → ACNP
Volume
78
Issue
8
Year of publication
1999
Pages
716 - 721
Database
ISI
SICI code
0001-6349(199909)78:8<716:HEOLUO>2.0.ZU;2-Z
Abstract
Background This report comprises women from one center, who all participate d in a larger European multi-center study, which included 2758 healthy wome n, of whom 1821 were randomly allocated to the levonorgestrel-releasing int rauterine system (Lng-IUS) and 937 to a copper-IUD (Nova-T). At the end of the 5 year study period, 109 of the 300 women, who originally were allocate d to the Lng-IUS at this center, were still using the Lng-IUS. The women we re offered the opportunity to continue the Lng-IUS and 100 women chose to d o so. After a total period of almost 7 years of continuous use, a second Ln g-IUS was offered and 82 of the women chose to start a second segment of Ln g-IUS use. After another 5 years, 69 of the women were fitted with their th ird Lng-IUS. Methods. These 82 women were examined yearly throughout the study period an d bleeding pattern, hemoglobin, weight, blood-pressure, general well-being and intercurrent disease were analyzed to assess long-term effects. Results. No pregnancy occurred during the follow-up. One case of partial ex pulsion occurred and one case of pelvic inflammatory disease. Seventy-seven percent of the women did not report any health problems at all during the entire follow-up period of 13 years. At the end of the second period with t he Lng-IUS, 60% reported amenorrhea, 12% infrequent, scanty bleeds and 28% regular, scanty bleeds. As a consequence, the hemoglobin values increased, with a mean increase, after 12-13 years, being 1.35 g/dl. Blood pressure in creased slightly and body weight increased with a mean increase of 0.49 kg/ year. Seven women became postmenopausal during the follow-up and started es trogen replacement therapy with the Lng-IUS in situ. Conclusions. This follow-up study suggests that the Lng-IUS remains a safe and effective method of contraception, allowing women prolonged relief of m enstrual problems, and for women in their late reproductive years, offering a convenient and bleeding-free transition into the menopause.